IBDEI0XH ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16612,1,4,0)
 ;;=4^Pregnancy Exam/Test
 ;;^UTILITY(U,$J,358.3,16612,2)
 ;;=^331589
 ;;^UTILITY(U,$J,358.3,16613,0)
 ;;=V67.01^^108^1046^69
 ;;^UTILITY(U,$J,358.3,16613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16613,1,3,0)
 ;;=3^V67.01
 ;;^UTILITY(U,$J,358.3,16613,1,4,0)
 ;;=4^Pap Smear Following Surgery
 ;;^UTILITY(U,$J,358.3,16613,2)
 ;;=^322078
 ;;^UTILITY(U,$J,358.3,16614,0)
 ;;=627.4^^108^1046^12
 ;;^UTILITY(U,$J,358.3,16614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16614,1,3,0)
 ;;=3^627.4
 ;;^UTILITY(U,$J,358.3,16614,1,4,0)
 ;;=4^Artificial Menopause-Symptomatic
 ;;^UTILITY(U,$J,358.3,16614,2)
 ;;=^328736
 ;;^UTILITY(U,$J,358.3,16615,0)
 ;;=793.80^^108^1046^3
 ;;^UTILITY(U,$J,358.3,16615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16615,1,3,0)
 ;;=3^793.80
 ;;^UTILITY(U,$J,358.3,16615,1,4,0)
 ;;=4^Abnormal Mammogram
 ;;^UTILITY(U,$J,358.3,16615,2)
 ;;=^323613
 ;;^UTILITY(U,$J,358.3,16616,0)
 ;;=V76.47^^108^1046^86
 ;;^UTILITY(U,$J,358.3,16616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16616,1,3,0)
 ;;=3^V76.47
 ;;^UTILITY(U,$J,358.3,16616,1,4,0)
 ;;=4^Special Screening for vaginal Malignant Neoplasms
 ;;^UTILITY(U,$J,358.3,16616,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,16617,0)
 ;;=V45.77^^108^1046^8
 ;;^UTILITY(U,$J,358.3,16617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16617,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,16617,1,4,0)
 ;;=4^Acquired Absence of Uterus
 ;;^UTILITY(U,$J,358.3,16617,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,16618,0)
 ;;=233.1^^108^1046^19
 ;;^UTILITY(U,$J,358.3,16618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16618,1,3,0)
 ;;=3^233.1
 ;;^UTILITY(U,$J,358.3,16618,1,4,0)
 ;;=4^CA in Situ (Sev. Dysplasia)
 ;;^UTILITY(U,$J,358.3,16618,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,16619,0)
 ;;=789.00^^108^1046^1
 ;;^UTILITY(U,$J,358.3,16619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16619,1,3,0)
 ;;=3^789.00
 ;;^UTILITY(U,$J,358.3,16619,1,4,0)
 ;;=4^Abdom Pain, Unsp Site
 ;;^UTILITY(U,$J,358.3,16619,2)
 ;;=^303317
 ;;^UTILITY(U,$J,358.3,16620,0)
 ;;=795.09^^108^1046^2
 ;;^UTILITY(U,$J,358.3,16620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16620,1,3,0)
 ;;=3^795.09
 ;;^UTILITY(U,$J,358.3,16620,1,4,0)
 ;;=4^Abn Pap Cervix HPV NEC
 ;;^UTILITY(U,$J,358.3,16620,2)
 ;;=^331974
 ;;^UTILITY(U,$J,358.3,16621,0)
 ;;=V45.77^^108^1046^7
 ;;^UTILITY(U,$J,358.3,16621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16621,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,16621,1,4,0)
 ;;=4^Acq Absence Org,Genitals
 ;;^UTILITY(U,$J,358.3,16621,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,16622,0)
 ;;=215.9^^108^1046^16
 ;;^UTILITY(U,$J,358.3,16622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16622,1,3,0)
 ;;=3^215.9
 ;;^UTILITY(U,$J,358.3,16622,1,4,0)
 ;;=4^Ben Neo Soft Tissue NOS
 ;;^UTILITY(U,$J,358.3,16622,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,16623,0)
 ;;=221.2^^108^1046^17
 ;;^UTILITY(U,$J,358.3,16623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16623,1,3,0)
 ;;=3^221.2
 ;;^UTILITY(U,$J,358.3,16623,1,4,0)
 ;;=4^Benign Neoplasm Vulva
 ;;^UTILITY(U,$J,358.3,16623,2)
 ;;=^267650
 ;;^UTILITY(U,$J,358.3,16624,0)
 ;;=795.05^^108^1046^20
 ;;^UTILITY(U,$J,358.3,16624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16624,1,3,0)
 ;;=3^795.05
 ;;^UTILITY(U,$J,358.3,16624,1,4,0)
 ;;=4^Cervical (HPV) DNA POS
 ;;^UTILITY(U,$J,358.3,16624,2)
 ;;=^331573
 ;;^UTILITY(U,$J,358.3,16625,0)
 ;;=701.0^^108^1046^23
 ;;^UTILITY(U,$J,358.3,16625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16625,1,3,0)
 ;;=3^701.0
 ;;^UTILITY(U,$J,358.3,16625,1,4,0)
 ;;=4^Circumscribe Scleroderma
 ;;^UTILITY(U,$J,358.3,16625,2)
 ;;=^108577
